The Journal of Experimental Medicine
Janeway's Immunobiology 7th Edition
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online June 2, 2008
doi:10.1084/jem.20070846
The Journal of Experimental Medicine, Vol. 205, No. 6, 1435-1446
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Frommhold et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Frommhold, D.
Right arrow Articles by Sperandio, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frommhold, D.
Right arrow Articles by Sperandio, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation

David Frommhold1, Andreas Ludwig2, M. Gabriele Bixel3, Alexander Zarbock4,9, Inna Babushkina1, Melitta Weissinger1, Sandra Cauwenberghs2, Lesley G. Ellies5, Jamey D. Marth6, Annette G. Beck-Sickinger7, Michael Sixt8, Bärbel Lange-Sperandio10, Alma Zernecke2, Ernst Brandt11, Christian Weber2, Dietmar Vestweber3, Klaus Ley4, and Markus Sperandio12

1 Children's Hospital, University of Heidelberg, 69120 Heidelberg, Germany
2 Institute of Molecular Cardiovascular Research, RWTH Aachen, 52074 Aachen, Germany
3 Max-Planck-Institute for Molecular Biomedicine, 48149 Muenster, Germany
4 La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037
5 Department of Pathology and 6 Department of Cellular and Molecular Medicine and Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA 92093
7 Institute of Biochemistry, University of Leipzig, 04103 Leipzig, Germany
8 Max-Planck-Institute for Biochemistry, 82152 Martinsried, Germany
9 Department of Anesthesiology and Critical Care Medicine, University of Muenster, 48149 Muenster, Germany
10 Dr. v. Haunersches Children's Hospital, Ludwig-Maximilians-Universität, 80336 Munich, Germany
11 Research Center Borstel, 23845 Borstel, Germany
12 Walter Brendel Center for Experimental Medicine, Ludwig-Maximilians-Universität, 81377 Munich, Germany

CORRESPONDENCE Markus Sperandio: markus.sperandio{at}med.uni-muenchen.de

Recent in vitro studies have suggested a role for sialylation in chemokine receptor binding to its ligand (Bannert, N., S. Craig, M. Farzan, D. Sogah, N.V. Santo, H. Choe, and J. Sodroski. 2001. J. Exp. Med. 194:1661–1673). This prompted us to investigate chemokine-induced leukocyte adhesion in inflamed cremaster muscle venules of {alpha}2,3 sialyltransferase (ST3Gal-IV)-deficient mice. We found a marked reduction in leukocyte adhesion to inflamed microvessels upon injection of the CXCR2 ligands CXCL1 (keratinocyte-derived chemokine) or CXCL8 (interleukin 8). In addition, extravasation of ST3Gal-IV–/– neutrophils into thioglycollate-pretreated peritoneal cavities was significantly decreased. In vitro assays revealed that CXCL8 binding to isolated ST3Gal-IV–/– neutrophils was markedly impaired. Furthermore, CXCL1-mediated adhesion of ST3Gal-IV–/– leukocytes at physiological flow conditions, as well as transendothelial migration of ST3Gal-IV–/– leukocytes in response to CXCL1, was significantly reduced. In human neutrophils, enzymatic desialylation decreased binding of CXCR2 ligands to the neutrophil surface and diminished neutrophil degranulation in response to these chemokines. In addition, binding of {alpha}2,3-linked sialic acid–specific Maackia amurensis lectin II to purified CXCR2 from neuraminidase-treated CXCR2-transfected HEK293 cells was markedly impaired. Collectively, we provide substantial evidence that sialylation by ST3Gal-IV significantly contributes to CXCR2-mediated leukocyte adhesion during inflammation in vivo.


Abbreviations used: CF-CXCL8, human carboxyfluorescein-labeled CXCL8; fMLP, N-formyl-Met-Leu-Phe; GPCR, G{alpha}i protein–coupled receptor; ICAM-1, intercellular adhesion molecule 1; MAL-II, Maackia amurensis lectin II; PTx, pertussis toxin; ST3Gal-IV, {alpha}2,3 sialyltransferase; WBC, white blood cell.

D. Frommhold and A. Ludwig contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS